IFNB1 and chronic hepatitis C virus infection: IFN-β treatment can lead to a significant reduction in the expression of miR-122 levels in vitro[11], although no significant correlation has been observed between miR-122 levels and serum HCV RNA titer in chronic hepatitis C patients with IFN-α therapy [21].